Vaxart Analyst Ratings
Vaxart Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 419.68% | Cantor Fitzgerald | $6 → $4 | Maintains | Overweight |
| 12/19/2022 | 94.88% | B. Riley Securities | $6 → $1.5 | Maintains | Neutral |
| 09/02/2022 | 939.37% | Cantor Fitzgerald | $11 → $8 | Maintains | Overweight |
| 05/19/2022 | 679.52% | B. Riley Securities | $7 → $6 | Maintains | Neutral |
| 11/02/2021 | 1848.81% | Cantor Fitzgerald | → $15 | Initiates Coverage On | → Overweight |
| 06/30/2021 | 1069.29% | B. Riley Securities | $13 → $9 | Downgrades | Buy → Neutral |
| 06/24/2021 | 1588.97% | Jefferies | → $13 | Initiates Coverage On | → Buy |
| 06/11/2021 | 2238.57% | Piper Sandler | → $18 | Initiates Coverage On | → Overweight |
| 08/12/2020 | 2108.65% | HC Wainwright & Co. | $7 → $17 | Maintains | Buy |
| 07/13/2020 | 2758.26% | B. Riley Securities | → $22 | Initiates Coverage On | → Buy |
| 04/30/2020 | 809.45% | HC Wainwright & Co. | $3 → $7 | Reiterates | → Buy |
| 06/27/2019 | 159.84% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/07/2023 | 419.68% | 坎託·菲茨傑拉德 | 6 美元 → 4 美元 | 維護 | 超重 |
| 2022 年 12 月 19 日 | 94.88% | B. 萊利證券 | 6 美元 → 1.5 美元 | 維護 | 中立 |
| 09/02/2022 | 939.37% | 坎託·菲茨傑拉德 | 11 美元 → 8 美元 | 維護 | 超重 |
| 05/19/2022 | 679.52% | B. 萊利證券 | 7 美元 → 6 美元 | 維護 | 中立 |
| 11/02/2021 | 1848.81% | 坎託·菲茨傑拉德 | → 15 美元 | 啓動覆蓋開啓 | → 超重 |
| 2021 年 6 月 30 日 | 1069.29% | B. 萊利證券 | 13 美元 → 9 美元 | 降級 | 買入 → 中性 |
| 2021 年 6 月 24 日 | 1588.97% | 傑富瑞 | → 13 美元 | 啓動覆蓋開啓 | → 購買 |
| 06/11/2021 | 2238.57% | 派珀·桑德勒 | → 18 美元 | 啓動覆蓋開啓 | → 超重 |
| 08/12/2020 | 2108.65% | HC Wainwright & Co. | 7 美元 → 17 美元 | 維護 | 購買 |
| 07/13/2020 | 2758.26% | B. 萊利證券 | → 22 美元 | 啓動覆蓋開啓 | → 購買 |
| 2020 年 4 月 30 日 | 809.45% | HC Wainwright & Co. | 3 美元 → 7 美元 | 重申 | → 購買 |
| 06/27/2019 | 159.84% | HC Wainwright & Co. | → 2 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Vaxart (VXRT)?
Vaxart (VXRT) 的目標價格是多少？
The latest price target for Vaxart (NASDAQ: VXRT) was reported by Cantor Fitzgerald on August 7, 2023. The analyst firm set a price target for $4.00 expecting VXRT to rise to within 12 months (a possible 419.68% upside). 3 analyst firms have reported ratings in the last year.
坎託·菲茨傑拉德於2023年8月7日公佈了Vaxart（納斯達克股票代碼：VXRT）的最新目標股價。這家分析公司將目標股價定爲4.00美元，預計VXRT將在12個月內升至419.68％（可能上漲419.68％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Vaxart (VXRT)?
分析師對Vaxart (VXRT) 的最新評級是多少？
The latest analyst rating for Vaxart (NASDAQ: VXRT) was provided by Cantor Fitzgerald, and Vaxart maintained their overweight rating.
Vaxart（納斯達克股票代碼：VXRT）的最新分析師評級由坎託·菲茨傑拉德提供，Vaxart維持增持評級。
When is the next analyst rating going to be posted or updated for Vaxart (VXRT)?
Vaxart (VXRT) 的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vaxart, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vaxart was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究（包括瀏覽公開財務報表、與Vaxart的高管和客戶交談以及聽取業績電話會議）後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。Vaxart的最後一次評級是在2023年8月7日提交的，因此您應該預計下一個評級將在2024年8月7日左右公佈。
Is the Analyst Rating Vaxart (VXRT) correct?
分析師對 Vaxart (VXRT) 的評級是否正確？
While ratings are subjective and will change, the latest Vaxart (VXRT) rating was a maintained with a price target of $6.00 to $4.00. The current price Vaxart (VXRT) is trading at is $0.77, which is out of the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的Vaxart（VXRT）評級維持不變，目標股價爲6.00美元至4.00美元。Vaxart（VXRT）目前的交易價格爲0.77美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。